Vol.

No.

February 02, 2018Feb 02, 2018

DOWNLOAD THE PDF

Cover Story

Like it or not, CMS policy aims to change everything in Next generation sequencing

A policy now in the works at the Centers for Medicare and Medicaid Services will define settings where Medicare will pay for next generation sequencing.

Dear CMS, Here's what I think about your NGS policy...
Agency draft memo garners 315 comments

By Paul Goldberg

Conversation with The Cancer Letter

Miller: “Doctors and patients have confidence in knowing that a test has gone through FDA”

By Paul Goldberg

Clinical Trials & Tribulations

Re: Drug Pricing My unsolicited advice to HHS Secretary Alex Azar

By Patricia J. Goldsmith

In Brief

Mays Family Foundation makes legacy gift of $30 million to UT Health San Antonio Cancer Center

Sylvester Comprehensive Cancer Center to build proton therapy program

Syapse partners with Seoul National University Hospital and Megazone

Buchholz named medical director at Scripps MD Anderson Cancer Center

Kati Stoermer named executive director NRG Oncology

James Wade joins Vibrent Health as chief medical informatics officer

SU2C announces $11 million multi-disciplinary research program

Chen, Bild, Kahn, Heisterkamp join City of Hope

New building expands inpatient care at Siteman Cancer Center

CancerCare raises nearly $665,000 to support patients affected by hurricanes

Cancer Support Community adds Digital Nonprofit MyLifeLine to its network

Funding Opportunities

AACR announces AACR-J&J lung cancer innovation science grants

Clinical Roundup

Trial shows durable remissions with Kymriah in children, young adults with r/r ALL

Drugs & Targets

FDA approves lutetium Lu 177 dotatate for treatment of GEP-NETS

Amgen receives CHMP positive opinion to add updated survival data to Kyprolis label

Syndax announces immuno-oncology collaboration with AstraZeneca

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues